Takeda Pharmaceutical Co Ltd
TAK14.605USD
+0.175+1.21%
시장 운영 시간 （ET）시세는 15분 지연됩니다
22.81B시가총액
0.21P/E TTM
자세한 내용은 Takeda Pharmaceutical Co Ltd 회사
Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research and development, manufacture, sale and licensing of pharmaceuticals. The Company focuses on the main business areas of gastrointestinal diseases, rare diseases, plasma derivatives (immune diseases), oncology (cancer), and neuroscience (neuropsychiatric diseases). The Company focuses on three research and development areas: innovative biopharmaceuticals with the focus on gastrointestinal and inflammatory diseases, neuroscience, and oncology, plus plasma derivatives and vaccines. Most of the pharmaceuticals treat rare diseases in the focus disease areas and the plasma derivatives area. The Company operates in Japan, the United States, Europe, and China.
회사 정보
종목 코드 TAK
회사 이름Takeda Pharmaceutical Co Ltd
상장일May 16, 1949
CEOMr. Christophe Weber
직원 수47455
유형Depository Receipt
회계 연도 종료May 16
주소4F
도시CHUO-KU
증권 거래소NYSE Consolidated
국가Japan
우편 번호103-8668
전화81332782111
웹사이트https://www.takeda.com/
종목 코드 TAK
상장일May 16, 1949
CEOMr. Christophe Weber
회사 임원
이름
이름/직위
직위
주식 보유
변동
Dr. Steven H. (Steve) Gillis, Ph.D.
Dr. Steven H. (Steve) Gillis, Ph.D.
Independent Director
Independent Director
8.26K
--
Ms. Kimberly A. Reed
Ms. Kimberly A. Reed
Independent Director
Independent Director
1.38K
-85.30%
Mr. Christophe Weber
Mr. Christophe Weber
President, Chief Executive Officer, Representative Director
President, Chief Executive Officer, Representative Director
--
--
Ms. Emiko Higashi
Ms. Emiko Higashi
Independent Director
Independent Director
--
--
Dr. John M. Maraganore, Ph.D.
Dr. John M. Maraganore, Ph.D.
Independent Director
Independent Director
--
--
Ms. Miki Tsusaka
Ms. Miki Tsusaka
Independent Director
Independent Director
--
--
Mr. Koji Hatsukawa
Mr. Koji Hatsukawa
Independent Director
Independent Director
--
--
Mr. Milano Furuta
Mr. Milano Furuta
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Mr. Masami Iijima
Mr. Masami Iijima
Chairman of Board of Directors, Independent Director
Chairman of Board of Directors, Independent Director
--
--
Dr. Andrew S. Plump, Ph.D.
Dr. Andrew S. Plump, Ph.D.
President of Research & Development, Director
President of Research & Development, Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Steven H. (Steve) Gillis, Ph.D.
Dr. Steven H. (Steve) Gillis, Ph.D.
Independent Director
Independent Director
8.26K
--
Ms. Kimberly A. Reed
Ms. Kimberly A. Reed
Independent Director
Independent Director
1.38K
-85.30%
Mr. Christophe Weber
Mr. Christophe Weber
President, Chief Executive Officer, Representative Director
President, Chief Executive Officer, Representative Director
--
--
Ms. Emiko Higashi
Ms. Emiko Higashi
Independent Director
Independent Director
--
--
Dr. John M. Maraganore, Ph.D.
Dr. John M. Maraganore, Ph.D.
Independent Director
Independent Director
--
--
Ms. Miki Tsusaka
Ms. Miki Tsusaka
Independent Director
Independent Director
--
--
수익 분석
통화: JPY마지막 업데이트: Sun, Jul 6
통화: JPY마지막 업데이트: Sun, Jul 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
사업별JPY
이름
수익
비율
Pharmaceutical Business
4.50T
98.13%
Intellectual Property And Service Revenue
85.58B
1.87%
지역별JPY
이름
수익
비율
United States
2.38T
51.94%
Europe And Canada (Country)
1.06T
23.03%
Japan
418.46B
9.13%
Latin America
235.85B
5.15%
China (Country)
191.74B
4.19%
Other
300.60B
6.56%
사업별
지역별
사업별JPY
이름
수익
비율
Pharmaceutical Business
4.50T
98.13%
Intellectual Property And Service Revenue
85.58B
1.87%
주식 보유 통계
마지막 업데이트: Sat, Aug 9
마지막 업데이트: Sat, Aug 9
주주
주주 유형
주주
주주
비율
Capital Research Global Investors
0.42%
Parametric Portfolio Associates LLC
0.17%
Fidelity Management & Research Company LLC
0.12%
Brandes Investment Partners, L.P.
0.11%
Adage Capital Management, L.P.
0.11%
Other
99.07%
주주
주주
비율
Capital Research Global Investors
0.42%
Parametric Portfolio Associates LLC
0.17%
Fidelity Management & Research Company LLC
0.12%
Brandes Investment Partners, L.P.
0.11%
Adage Capital Management, L.P.
0.11%
Other
99.07%
주주 유형
주주
비율
Investment Advisor
1.59%
Hedge Fund
0.30%
Investment Advisor/Hedge Fund
0.24%
Research Firm
0.14%
Family Office
0.01%
Family Office
0.01%
Family Office
0.01%
Other
97.69%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
594
72.78M
2.30%
-6.62M
2025Q1
603
72.05M
2.31%
-7.59M
2024Q4
595
73.56M
2.33%
-9.88M
2024Q3
583
77.60M
2.45%
-3.33M
2024Q2
581
73.43M
2.34%
-14.54M
2024Q1
593
78.98M
2.52%
-11.62M
2023Q4
609
83.80M
2.67%
-18.91M
2023Q3
621
81.24M
2.59%
-37.59M
2023Q2
617
84.64M
2.72%
-34.14M
2023Q1
627
84.81M
2.73%
-21.74M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Capital Research Global Investors
13.20M
0.42%
+38.49K
+0.29%
Mar 31, 2025
Parametric Portfolio Associates LLC
5.29M
0.17%
+157.07K
+3.06%
Mar 31, 2025
Fidelity Management & Research Company LLC
3.81M
0.12%
+478.81K
+14.38%
Mar 31, 2025
Brandes Investment Partners, L.P.
3.50M
0.11%
+464.56K
+15.28%
Mar 31, 2025
Adage Capital Management, L.P.
3.43M
0.11%
+3.43M
--
Mar 31, 2025
Renaissance Technologies LLC
3.16M
0.1%
+78.30K
+2.54%
Mar 31, 2025
Goldman Sachs Asset Management, L.P.
2.89M
0.09%
+577.36K
+24.92%
Mar 31, 2025
First Trust Advisors L.P.
2.76M
0.09%
-484.98K
-14.96%
Mar 31, 2025
Aperio Group, LLC
2.63M
0.08%
+426.92K
+19.37%
Mar 31, 2025
Van Eck Associates Corporation
2.17M
0.07%
-38.04K
-1.72%
Mar 31, 2025
더 보기
관련 ETF
마지막 업데이트: Wed, Aug 6
마지막 업데이트: Wed, Aug 6
이름
비율
SGI Enhanced Global Income ETF
2.21%
VanEck Pharmaceutical ETF
2.05%
Adasina Social Justice All Cap Global ETF
0.58%
Invesco Zacks Multi-Asset Income ETF
0.45%
First Trust Value Line Dividend Index Fund
0.44%
ActivePassive International Equity ETF
0.43%
Avantis International Equity ETF
0.07%
Avantis Responsible International Equity ETF
0.07%
Roundhill GLP-1 & Weight Loss ETF
0%
DFA Dimensional International Core Equity 2 ETF
0%
더 보기
SGI Enhanced Global Income ETF
비율2.21%
VanEck Pharmaceutical ETF
비율2.05%
Adasina Social Justice All Cap Global ETF
비율0.58%
Invesco Zacks Multi-Asset Income ETF
비율0.45%
First Trust Value Line Dividend Index Fund
비율0.44%
ActivePassive International Equity ETF
비율0.43%
Avantis International Equity ETF
비율0.07%
Avantis Responsible International Equity ETF
비율0.07%
Roundhill GLP-1 & Weight Loss ETF
비율0%
DFA Dimensional International Core Equity 2 ETF
비율0%
주식 배당금
지난 5년 동안 총
1.44T
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
Sep 12, 2024
TAK.NB Final Cash Dividend of gross USD 0.326079 paid on Dec 12, 2024 going ex on Sep 30, 2024
Sep 30, 2024
Dec 12, 2024
Sep 30, 2024
Mar 14, 2024
TAK.NB Interim Cash Dividend of gross USD 0.292214 paid on Jul 08, 2024 going ex on Mar 27, 2024
Mar 28, 2024
Jul 08, 2024
Mar 27, 2024
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
